{"transactions":[{"id":3627452,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":159751,"kind":"person","name":"Ahn Edward S.","position":1,"cik":"0001623597","reported_name":"Ahn Edward S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech & Strategy Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-28T21:30:23.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":5625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The exercise price of the stock options represents the closing price of the Company's common stock on the grant date, January 24, 2018, the date the Compensation Committee of the Company granted these performance-based stock option awards (the \"Performance Grant\"). Please also see notes 3 and 4."},{"field":"date","element":"transactionDate","label":"F3","text":"On February 27, 2019, the Compensation Committee determined and certified that 63.9% of the initial Performance Grant had been earned, subject to time-based vesting. Please also see notes 2 and 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock options vest in four equal installments on the following dates: February 27, 2019, January 1, 2020, January 1, 2021, and January 1, 2022."}],"balance_after":5625,"derivative":{"exercise_price":61.47,"expiration_date":"2028-01-24","underlying":"Common Stock","underlying_shares":5625},"source":{"system":"sec-edgar","filing":"0001171843-19-001382","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184319001382/ownership.xml","form_type":"4"}},{"id":3627451,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":159751,"kind":"person","name":"Ahn Edward S.","position":1,"cik":"0001623597","reported_name":"Ahn Edward S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech & Strategy Officer"}}],"security":"Restricted Stock Unit","published_at":"2019-02-28T21:30:23.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":4500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning February 26, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning February 26, 2020."}],"balance_after":4500,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4500},"source":{"system":"sec-edgar","filing":"0001171843-19-001382","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184319001382/ownership.xml","form_type":"4"}},{"id":3672791,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":159751,"kind":"person","name":"Ahn Edward S.","position":1,"cik":"0001623597","reported_name":"Ahn Edward S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech & Strategy Officer"}}],"security":"Common Stock","published_at":"2019-02-06T14:15:26.000Z","date":"2019-02-04","kind":"tax_withholding","acquired":false,"shares":685,"price":38.1,"value":26098.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an aggregate of 685 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to restricted shares that vested in full on February 4, 2019."}],"balance_after":6575,"source":{"system":"sec-edgar","filing":"0001171843-19-000755","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184319000755/ownership.xml","form_type":"4"}},{"id":4021798,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":159751,"kind":"person","name":"Ahn Edward S.","position":1,"cik":"0001623597","reported_name":"Ahn Edward S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech & Strategy Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-02T21:07:12.000Z","date":"2018-03-02","kind":"grant","acquired":true,"shares":7788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options represents the closing price of the Company's common stock on the grant date, January 27, 2017, the date the Compensation Committee of the Company granted these performance-based stock option awards (the \"Performance Grant\"). Please also see notes 2 and 3."},{"field":"date","element":"transactionDate","label":"F2","text":"On March 2, 2018, the Compensation Committee determined and certified that 55% of the initial Performance Grant had been earned, subject to time-based vesting. Please also see notes 1 and 3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options vest in three equal installments on the following dates: March 2, 2018, January 1, 2019, and January 1, 2020."}],"balance_after":7788,"derivative":{"exercise_price":50.13,"expiration_date":"2027-01-27","underlying":"Common Stock","underlying_shares":7788},"source":{"system":"sec-edgar","filing":"0001171843-18-001659","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184318001659/formfour.xml","form_type":"4"}},{"id":4088829,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":159751,"kind":"person","name":"Ahn Edward S.","position":1,"cik":"0001623597","reported_name":"Ahn Edward S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech & Strategy Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-26T21:05:22.000Z","date":"2018-01-24","kind":"grant","acquired":true,"shares":13400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest in four equal annual installments beginning January 24, 2019."}],"balance_after":13400,"derivative":{"exercise_price":61.47,"expiration_date":"2028-01-24","underlying":"Common Stock","underlying_shares":13400},"source":{"system":"sec-edgar","filing":"0001171843-18-000687","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184318000687/formfour.xml","form_type":"4"}},{"id":4419067,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":159751,"kind":"person","name":"Ahn Edward S.","position":1,"cik":"0001623597","reported_name":"Ahn Edward S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech & Strategy Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-02-28T21:05:42.000Z","date":"2017-02-24","kind":"grant","acquired":true,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price of the stock options represents the closing price of the Company's common stock on the grant date, February 4, 2016, the date the Compensation Committee of the Company granted these performance-based stock option awards (the \"Performance Grant\"). Please also see notes 2 and 3."},{"field":"date","element":"transactionDate","label":"F2","text":"On February 24, 2017, the Compensation Committee determined and certified that 125% of the initial Performance Grant had been earned, subject to time-based vesting. Please also see notes 1 and 3."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock options vest in four equal installments on the following dates: February 24, 2017, January 1, 2018, January 1, 2019 and January 1, 2020."}],"balance_after":11500,"derivative":{"exercise_price":38.11,"expiration_date":"2026-02-04","underlying":"Common Stock","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0001171843-17-001205","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317001205/formfour.xml","form_type":"4"}},{"id":4419066,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":159751,"kind":"person","name":"Ahn Edward S.","position":1,"cik":"0001623597","reported_name":"Ahn Edward S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech & Strategy Officer"}}],"security":"Common Stock","published_at":"2017-02-28T21:05:42.000Z","date":"2017-02-24","kind":"sale","acquired":false,"shares":640,"price":49.47,"value":31660.8,"ownership":{"direct":true},"balance_after":7260,"source":{"system":"sec-edgar","filing":"0001171843-17-001205","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317001205/formfour.xml","form_type":"4"}},{"id":4475938,"issuer":{"id":6005,"kind":"organization","name":"Anika Therapeutics, Inc."},"owners":[{"id":159751,"kind":"person","name":"Ahn Edward S.","position":1,"cik":"0001623597","reported_name":"Ahn Edward S.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Tech & Strategy Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-31T21:05:19.000Z","date":"2017-01-27","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest in three equal annual installments beginning January 27, 2018."}],"balance_after":22500,"derivative":{"exercise_price":50.13,"expiration_date":"2027-01-27","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001171843-17-000583","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/898437/000117184317000583/formfour.xml","form_type":"4"}}]}